Navigation Links
InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
Date:4/1/2008

- Rapid and significant reductions in HCV RNA observed; well tolerated in

all dose cohorts - - Significant progress made in clinical, preclinical and formulation --

- Conference call and webcast today at 8:30 a.m. EDT --

BRISBANE, Calif., April 1, 2008 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN) today provided an overall program update and reported the top-line results from the four dose cohorts of treatment-naive patients in its ongoing Phase 1b clinical trial of ITMN-191, designated R7227 at Roche (SWX: ROG). ITMN-191 was administered as monotherapy in patients with chronic hepatitis C virus (HCV) genotype 1 infection. InterMune reported that treatment with ITMN-191 resulted in rapid and significant reductions in HCV RNA (see table below).

Total Daily Mean Maximum Reduction

Cohort Dose Dose (mg) HCV RNA Log10 IU/mL (range)

1 100 mg q12h 200 1.6 (0.9-2.2)

2 100 mg q8h 300 2.6 (1.7-3.6)

3 200 mg q12h 400 3.4 (2.4-4.4)

4 200 mg q8h 600 3.9 (3.0-5.0)

One final cohort consisting of treatment-experienced patients dosed at 300mg every 12 hours will begin dosing next week.

InterMune additionally reported that, based on a preliminary review of the available and still blinded clinical data from the four completed cohorts of the Phase 1b study, ITMN-191 was safe and well-tolerated. No serious adverse events were reported and no subject discontinued the study due to an adverse event. Adverse events were generally mild and transient in nature.

"With rapid and s
'/>"/>

SOURCE InterMune, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. InterMune Announces Start of Phase 1b Trial of ITMN-191
2. InterMune Announces Approval of Clinical Trial Authorization for Phase 1b Trial of ITMN-191
3. Bionovo Announces Publication of the Paper Detailing the Mechanism of Action of Its Cancer Drug BZL101
4. Kingfisher Announces FDA 510(k) Clearance of Breakthrough KFH Energy for Chronic Pain Sufferers
5. Genaera Corporation Announces MSI-1436 Data Presented at Society of Neuroscience Meeting
6. Keryx Biopharmaceuticals Announces Termination of SUN-MACRO Phase 4 Trial
7. Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update
8. Cystic Fibrosis Foundation Announces Positive Early Results for Phase 2 Clinical Trial of VX-770 - an Oral Compound to Treat CF
9. Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin
10. Nventa Announces Positive Interim Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial
11. Anacor Pharmaceuticals Announces Positive Results from Phase 2a Clinical Trial of AN2728 in Psoriasis Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... 2015  Lannett Company, Inc. (NYSE: LCI ) ... Canaccord Genuity 35th Annual Growth Conference on Wednesday, August ... Boston Hotel.  A webcast of the ... are encouraged to visit the web site at least ... to register, download and install any necessary software.  The ...
(Date:7/30/2015)... , July 30, 2015  Cleave Biosciences ... Trademark Office has granted the company a key ... Cleave,s lead molecule CB-5083. This newly ... inhibitors of p97," U.S. 9,062,026, allows for claims ... first-in-class, highly selective oral inhibitor of p97, a ...
(Date:7/30/2015)... 30, 2015 Flexpoint Ford, a private equity ... today announced that it has entered into a partnership ... to form Kastle Therapeutics, LLC (Kastle).  The new ... focus on acquiring, developing and commercializing pharmaceuticals targeted toward ... include select therapies already approved for marketing, as well ...
Breaking Medicine Technology:Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics 2Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics 3
... Alsius Corporation,(Nasdaq: ALUS ), the worldwide leader ... four scientific,posters featuring both patient cases and laboratory ... be presented this week at the American,Society of ... Dr. Arie Blitz, Director of Heart Transplantation ...
... Trial Results Disclosed, SAN DIEGO, Oct. ... developing "Best-in-Class" drugs for the,treatment of serious ... multiple studies on its lead program, TR-701, ... in eighteen presentations at the upcoming joint,Interscience ...
Cached Medicine Technology:Thermogard XP(TM) Studies to Be Presented at American Society of Anesthesiologists Annual Meeting 2Thermogard XP(TM) Studies to Be Presented at American Society of Anesthesiologists Annual Meeting 3Trius Antibiotics to be Highlighted in 18 Presentations at ICAAC/IDSA 2Trius Antibiotics to be Highlighted in 18 Presentations at ICAAC/IDSA 3
(Date:7/31/2015)... Raton, FL (PRWEB) , ... July 31, 2015 ... ... marketing and distribution of a wide variety of nutritional and wellness products, announced ... neuromuscular therapist that specializes in massage therapy, active isolated stretching and the prevention ...
(Date:7/31/2015)... ... July 31, 2015 , ... People love to ... disability insurance, where price is an important factor to clients when choosing to ... carrier, offers the Preferred Producer Multi-Life Discount program, where advisers pass savings onto ...
(Date:7/30/2015)... ... ... Dale Sky Jones, Executive Chancellor of Oaksterdam University , the first cannabis ... at the Caribe Royal All Suites Hotel and Convention Center in Orlando, Florida, October ... medical cannabis expo in the country and this year’s expo will be the first ...
(Date:7/30/2015)... (PRWEB) , ... July 31, 2015 , ... Committed to ... to action by asking community members to contribute to the College’s “My Brother’s Keeper ... of our young people stay on track. Providing the support they need to think ...
(Date:7/30/2015)... ... ... OSF Healthcare System has been recognized as one of the nation’s ... & Health Networks. This marks the fourth consecutive year for this achievement by the ... Third Order of St. Francis . , Health data security and patient engagement are ...
Breaking Medicine News(10 mins):Health News:NPI Welcomes Vincent Aquilino to Board of Directors 2Health News:Secura Consultants Gives Advisers Competitive New Edge with Multi-Life Discount Program 2Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 2Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 3Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 4Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 5Health News:Mercy College a “My Brother’s Keeper” Community 2Health News:Mercy College a “My Brother’s Keeper” Community 3Health News:OSF HealthCare Named One of the Most Wired Systems 2Health News:OSF HealthCare Named One of the Most Wired Systems 3
... Wellness through Education and Research InitiativesNEW YORK, April ... as a leadership contributor with the National Thoroughbred ... partnership,s aim is to ensure the health and ... accreditation program are addressed in a manner that ...
... Attention to Connecticut,s Growing Burden of Chronic Disease and Promote ... by CrisisHARTFORD, Conn., April 6 National and state health ... launch a Partnership to call for comprehensive health and economic ... in Connecticut and across the nation. , , ...
... Studies will chart recovery of active women with breast ... -- A Yale professor has received $7 million in ... ovarian and breast cancer recovery. , The U.S. ... that exercise along with traditional courses of treatment can ...
... identifies a protein that modifies the androgen receptor (AR) and ... progression of prostate cancer. The research, published by Cell Press ... Cell , may also drive creation of new strategies for ... to traditional anti-hormone therapies. , The AR is an ...
... joke that gets all the laughs. As funny as folks ... That,s one conclusion of a groundbreaking new paper from the ... the University of Toronto,s Rotman School of Management and the ... authors looked at the effect of sexual behavior in the ...
... is sweeping the countryCORDOVA, Tenn., April 6 Christian Companion ... practical and spiritual assistance, is opening an office in Cordova, ... The new office is located at 1160 Vickery Lane, Suite ... 1:30 p.m. and will last until 3:30 p.m. Free refreshments ...
Cached Medicine News:Health News:Pfizer Animal Health Becomes Leadership Contributor to the NTRA Safety and Integrity Alliance 2Health News:Pfizer Animal Health Becomes Leadership Contributor to the NTRA Safety and Integrity Alliance 3Health News:Bipartisan CT Coalition Forms to Fight Spiraling Health Care Costs 2Health News:Yale Plans Closer Look at Exercise and Cancer 2Health News:A potential new target for treatment of hormone refractory prostate cancer 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: